Published in Neoplasma on January 01, 1982
Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies. Oncogene (1991) 2.42
Autoradiographic study of mannan incorporation into the growing cell walls of Saccharomyces cerevisiae. J Bacteriol (1974) 1.94
Patterns of expression of the p53 tumour suppressor in human breast tissues and tumours in situ and in vitro. Int J Cancer (1990) 1.69
Possible linkage between uncoiler chromosome Un 1 and amylase polymorphism Amy 2 loci. Humangenetik (1971) 1.35
Differential expression of keratin 19 in normal human epithelial tissues revealed by monospecific monoclonal antibodies. Histochem J (1986) 1.15
Effect of 2-deoxyglucose on cell wall formation in Saccharomyces cerevisiae and its relation to cell growth inhibition. J Bacteriol (1971) 1.13
p53 protein alterations in human testicular cancer including pre-invasive intratubular germ-cell neoplasia. Int J Cancer (1991) 1.01
Malignant melanoma associates with Th1/Th2 imbalance that coincides with disease progression and immunotherapy response. Neoplasma (2002) 1.00
Transcription protein STAT1: biology and relation to cancer. Folia Biol (Praha) (2007) 0.97
A series of 14 new monoclonal antibodies to keratins: characterization and value in diagnostic histopathology. J Pathol (1991) 0.95
HLA-DR antigens on differentiating human mammary gland epithelium and breast tumours. Br J Cancer (1987) 0.94
Longitudinal follow-up of antibody response to selected antigens of human papillomaviruses and herpesviruses in patients with invasive cervical carcinoma. Int J Cancer (2000) 0.91
A constitutional de novo mutation in exon 8 of the p53 gene in a patient with multiple primary malignancies. Br J Cancer (1996) 0.91
Expression of monoclonal antibody-defined epitopes of keratin 19 in human tumours and cultured cells. Eur J Cancer Clin Oncol (1986) 0.90
Microphthalmia transcription factor: a specific marker for malignant melanoma. Prague Med Rep (2004) 0.90
Vascular density in carcinoma of the uterine cervix and its predictive value for radiotherapy. Int J Cancer (1988) 0.87
Chronic toxicity and micronucleus assay of the new cardioprotective agent stobadine in rats. Arzneimittelforschung (1995) 0.87
Vascularization and radiocurability in cancer of the uterine cervix. A retrospective study. Neoplasma (1982) 0.86
Prognostic value of bone marrow biopsy in operable breast cancer patients at the time of initial diagnosis: Results of a 20-year median follow-up. Breast Cancer Res Treat (1998) 0.86
Mouse mammary tumor virus production stimulated by hormones and polyamines in cells grown in semi-synthetic in vitro conditions. Int J Cancer (1977) 0.85
Expression of p43 in breast cancer tissue, correlation with prognostic parameters. Cancer Lett (1992) 0.85
[The effects of endoxan on HeLa cells chromosomes]. Humangenetik (1967) 0.84
Viridans streptococcal bacteraemia due to penicillin-resistant and penicillin-sensitive streptococci: analysis of risk factors and outcome in 60 patients from a single cancer centre before and after penicillin is used for prophylaxis. Scand J Infect Dis (1997) 0.84
Interferon-alpha treatment may negatively influence disease progression in melanoma patients by hyperactivation of STAT3 protein. Eur J Cancer (2009) 0.83
Inhibition of adhesion breast cancer cells by anticoagulant drugs and cimetidine. Neoplasma (2003) 0.83
Metastatic MHC class I-negative mouse cells derived by transformation with human papillomavirus type 16. Br J Cancer (2001) 0.82
Stimulation of differentiation in human melanoma cells by dimethyl sulphoxide (DMSO). Neoplasma (1985) 0.82
A panel of monoclonal antibodies to keratin no. 7: characterization and value in tumor diagnosis. Neoplasma (1990) 0.82
Human neoplastic cells in tissue culture: two established cell lines derived from giant cell tumor and fibrosarcoma. Neoplasma (1976) 0.82
Is cancer a macrophage-mediated autoaggressive disease? Lancet (1987) 0.82
Rare somatic p53 mutation identified in breast cancer: a case report. Tumour Biol (2001) 0.82
Resistance pattern of 2816 isolates isolated from 17631 blood cultures and etiology of bacteremia and fungemia in a single cancer institution. Acta Oncol (1997) 0.81
Psychotropic drugs and ovarial cycle alterations. Act Nerv Super (Praha) (1974) 0.80
Funguria in cancer patients: analysis of risk factors, clinical presentation and outcome in 50 patients. Infection (1997) 0.80
Increased sensitivity of a plasma cell tumour to T.E.M. on conversion to the ascitic form: relationship to karyotype and cycle kinetics. Neoplasma (1969) 0.80
[Effect of the chain length of oligonucleotides on interferon induction]. Naturwissenschaften (1969) 0.80
Placental isoferritin associated p43 antigen correlates with features of high differentiation in breast cancer. Breast Cancer Res Treat (1992) 0.80
Chromosomal aberrations, sister chromatid exchange (SCEs) and micronuclei induction with three platinum compounds (cis-DDP, CHIP, CBDCA) in V79 cells in vitro. Neoplasma (1984) 0.80
Isolation of melanosomes from keratinous material-a new method. Dermatologica (1972) 0.80
Cell wall formation in yeast. An electron microscopic autoradiographic study. Arch Mikrobiol (1973) 0.80
Ploidy studies in ovarian cancer during cytostatic treatment. Neoplasma (1969) 0.80
Risk factors, aetiology, therapy and outcome in 123 episodes of breakthrough bacteraemia and fungaemia during antimicrobial prophylaxis and therapy in cancer patients. J Med Microbiol (1997) 0.80
Ciprofloxacin plus vancomycin versus ceftazidime plus gentamicin in the treatment of pneumonia in granulocytopenic patients with or without venous catheters. Short communication. Chemotherapy (1992) 0.80
Immunosuppression by breast cancer associated p43-effect of immunomodulators. Breast Cancer Res Treat (1996) 0.79
Imipenem-resistant Ps. aeruginosa bacteraemia in cancer patients: risk factors, clinical features and outcome. Bratisl Lek Listy (1996) 0.79
Continuous production of avian sarcoma virus B77 by rat tumour cells in tissue culture. Int J Cancer (1969) 0.79
Distribution of zinc and copper in pigmented tissues. Hoppe Seylers Z Physiol Chem (1973) 0.79
In vitro evaluation of the cytotoxicity and genotoxicity of resorcylidene aminoguanidine in human diploid cells B-HNF-1. Folia Biol (Praha) (2008) 0.79
A freeze-etch study of occurrence of nuclear pores in normal and tumor cells. Neoplasma (1975) 0.78
Downregulation of lymphocyte mitogenesis by breast cancer-associated p43. Cancer Lett (1994) 0.78
In vitro inhibition of human cytomegalovirus replication by calcium trinatrium diethylenetriaminepentaacetic acid. Antiviral Res (1996) 0.78
Formaldehyde release characteristics from a Swedish floor finish. Bull Environ Contam Toxicol (1988) 0.78
Expression of p43 associated placental isoferritin (PLF) correlates inversely with cell growth in breast cancer cell lines MCF-7 and T47-D. Neoplasma (1993) 0.78
In vitro micronucleus test of the cardioprotective agent stobadine. A genotoxicological study. Pharmazie (1993) 0.78
Lack of STAT 1 phosphorylation at TYR 701 by IFNgamma correlates with disease outcome in melanoma patients. Neoplasma (2005) 0.78
Quantitative parameters of melanomas differentiation. Neoplasma (1978) 0.77
The hair melanosome: another tissue reservoir of zinc. Physiol Bohemoslov (1976) 0.77
Course of breast cancer disease and ABO blood groups. Biomed Pharmacother (1985) 0.77
[Health status of workers exposed to styrene used in the manufacture of glass laminates]. Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl (1989) 0.77
Mammalian tropism of B77(RBI) virus. Expression of virus genome in the hamster sarcoma cell clones. Neoplasma (1975) 0.77
Secretory component in differentiating normal epithelium, benign lesions and malignancy in the human breast as monitored by monoclonal antibodies. Histochemistry (1989) 0.77
Tumor progression of murine epidermal cells after treatment in vitro with 12-O-tetradecanoylphorbol-13-acetate or retinoic acid. Cancer Res (1991) 0.77
Effects of tissue fixation conditions and protease pretreatment on immunohistochemical performance of a large series of new anti-keratin monoclonal antibodies: value in oncopathology. Neoplasma (1991) 0.77
Differentiation patterns of testicular germ-cell tumours as revealed by a panel of monoclonal antibodies. Tumour Biol (1987) 0.77
Role of natural prostaglandins in the control of murine mammary tumor virus expression. J Cancer Res Clin Oncol (1982) 0.77
Cytotoxic interactions of Zn2+ in vitro: melanoma cells are more susceptible than melanocytes. Melanoma Res (1997) 0.77
Netilmicin plus ceftriaxone versus amikacin plus ceftriaxone in the treatment of infections in granulocytopenic patients. Chemotherapy (1992) 0.77
Imipenen-resistant Ps. aeruginosa bacteraemia in cancer patients: risk factors, clinical features and outcome. Int J Clin Pharmacol Res (1996) 0.77
Ultrastructure of human uveal melanomas cultivated in vitro. Neoplasma (1976) 0.77
Evaluation of serum sialic acid fractions as markers for malignant melanoma. Cancer Lett (1994) 0.77
Autofluorescence of melanins induced by ultraviolet radiation and near ultraviolet light. A histochemical and biochemical study. Histochem J (2001) 0.77
Interferon inducibility of STAT 1 activation and its prognostic significance in melanoma patients. Folia Biol (Praha) (2003) 0.77
The influence of N-(2-hydroxyethyl)-palmitamide on virus-induced sarcomas in chickens and Rauscher leukemia in mice. Neoplasma (1975) 0.76
[The dynamics of psychosocial burden development in breast cancer survivors: clinical success with psychosocial consequences]. Klin Onkol (2011) 0.76
DNCB and PPD skin testing in breast cancer. Neoplasma (1983) 0.76
Estrogenic effect in vaginal smears in cancer of the uterine cervix. Neoplasma (1978) 0.76
The effect of zinc on mouse melanoma growth in vitro and in vivo. Neoplasma (1985) 0.76
Renal cell carcinoma-associated immune impairment that may interfere with the response to cytokine therapy. Neoplasma (1999) 0.76
Influence of chloramphenicol on the reunion frequency of cytoxan-induced chromosome breaks in HeLa cells. Mutat Res (1968) 0.76
Fusion-induced malignancy? A preliminary study. (a challenge to today's common wisdom). Neoplasma (1992) 0.76
[Distribution of zinc and copper in different-colored human hair]. Dermatol Monatsschr (1973) 0.76
Nephrotoxicity of aminoglycosides, polypeptides and cephalosporins in cancer patients. Chemotherapy (1991) 0.75
DNCB and PPD skin tests and prognosis in 152 patients with breast cancer. A prospective 2-year follow-up. Neoplasma (1985) 0.75
Isolation of melanosomes from keratinous structures: current state of the art. Arch Dermatol Res (1986) 0.75
p53 status in breast carcinomas revealed by FASAY correlates well with p53 protein accumulation determined by immunohistochemistry. Neoplasma (1999) 0.75
In vitro cytotoxicity in rabbit corneal cells of two new local anesthetics--pentacaine and heptacaine. Pharmazie (1981) 0.75
[The role of the Blatella germanica in transmission of infectious agents (author's transl)]. Cesk Epidemiol Mikrobiol Imunol (1975) 0.75
Lack of correlation between the carcinostatic effect and the inhibition of glycolysis caused by tris-(beta-chlorethyl)-amine. Chemotherapy (1970) 0.75
Bacteremia and fungemia in cancer patients with venous catheters. Neoplasma (1995) 0.75
[Protracted nosocomial epidemic due to the multiresistant Salmonella anatum strain (author's transl)]. Cesk Epidemiol Mikrobiol Imunol (1974) 0.75
Small wild rodents rabies in Czechoslovakia. J Hyg Epidemiol Microbiol Immunol (1982) 0.75
Ceftriaxone versus ceftazidime plus aminoglycoside therapy for infections in patients with neutropenia after cytotoxic chemotherapy. Short communication. Neoplasma (1993) 0.75
Organization of proviral DNA and protein composition of hormonally stimulated C57Bl/10 strain-associated mouse mammary tumor virus. Neoplasma (1981) 0.75
In vitro antiproliferative effect of interferon alpha in solid tumors: a potential predictive test. Neoplasma (1993) 0.75
Fungal pathogens in etiology of septic shock in neutropenic patients with cancer (short communication). Zentralbl Bakteriol (1993) 0.75
Accelerated appearance of an ascitic tumour after long-term application of interferon to NZB/W mice. Acta Virol (1981) 0.75